Guideline Summary for Evaluation and Management of Elevated BUN and Creatinine with Electrolyte Abnormalities

Diagnostic Criteria

An estimated glomerular filtration rate (eGFR) < 60 mL/min/1.73 m² persisting for > 3 months defines chronic kidney disease (CKD). 1
When eGFR is 45–59 mL/min/1.73 m² without other markers of kidney damage, measuring cystatin C can help confirm CKD and avoid mislabeling. 1

Multiple myeloma should be excluded in patients with elevated BUN/creatinine, abnormal calcium, and protein abnormalities by performing serum and urine protein electrophoresis with immunofixation and a serum free light‑chain assay. 2
Low serum albumin together with a high total protein level strongly suggests a paraproteinemia such as multiple myeloma. [3][2]
Diabetic kidney disease occurs in approximately 20–40 % of individuals with diabetes; therefore fasting glucose, HbA1c, and a spot urine albumin‑to‑creatinine ratio (ACR) are mandatory screening tests. 4
The spot urine ACR is the preferred test over total protein quantification for detecting albuminuria. [1][4]
Serum electrolytes, including bicarbonate, and serum phosphate should be obtained to assess for renal tubular acidosis and phosphate disorders. 4
Renal ultrasonography is recommended to evaluate kidney size and exclude obstructive causes. 4

Serum potassium should be checked every 6–24 hours initially, depending on severity, because hyperkalemia can precipitate life‑threatening arrhythmias. [5][4]
Hypercalcemia may indicate multiple myeloma or other malignancies, whereas hypocalcemia with concurrent hyperphosphatemia suggests advanced CKD. [5][2]

Medication review should include immediate discontinuation of non‑steroidal anti‑inflammatory drugs (NSAIDs) and temporary holding of ACE inhibitors or ARBs in the setting of volume depletion or acute kidney injury. 4
Renally cleared drug doses should be adjusted using the Cockcroft‑Gault formula; dosing errors occur in roughly 42 % of patients with renal insufficiency receiving antiplatelet or antithrombotic agents. 6

Target blood pressure < 130/80 mmHg in most patients with CKD. 4
Aim for glycemic control with HbA1c < 7 % in diabetic patients. 4
Initiate an ACE inhibitor or ARB when the urine albumin‑to‑creatinine ratio is ≥30 mg/g (strong recommendation when ≥300 mg/g or eGFR < 60 mL/min/1.73 m²). 4
Prescribe a dietary protein intake of approximately 0.8 g/kg/day for non‑dialysis patients. 4
When using renin‑angiotensin‑aldosterone system inhibitors, monitor serum creatinine and potassium periodically; an initial rise in creatinine up to 30 % is acceptable unless accompanied by hyperkalemia. 4

High‑risk patients (eGFR < 30 mL/min/1.73 m², rapidly declining function, or tumor‑lysis syndrome) should have vital signs, urine output, electrolytes (K⁺, Ca²⁺, PO₄³⁻), BUN, and creatinine checked every 6–12 hours initially, with daily weights and strict intake/output tracking. [5][4]
Stable CKD patients should have eGFR and urine ACR measured at least annually; monitoring frequency increases to 2–4 times per year when eGFR is 30–44 mL/min/1.73 m² or ACR > 300 mg/g, and quarterly when eGFR < 30 mL/min/1.73 m² or disease is rapidly progressive. [1][4]

Urgent referral (within days) is indicated for eGFR < 30 mL/min/1.73 m², or when the etiology of kidney dysfunction is uncertain. [4][3]
Routine referral (within weeks to months) is appropriate for persistent eGFR 30–44 mL/min/1.73 m², or eGFR 45–59 mL/min/1.73 m² with progressive decline or additional markers of kidney damage. [1][4]

Elevated BUN reflects decreased kidney excretory function and may indicate reduced renal blood flow or increased protein catabolism, according to the National Comprehensive Cancer Network 7, 8.
Creatinine elevation indicates decreased glomerular filtration and kidney function impairment, as stated by the American Heart Association, with a reference range of 0.57-1.00 mg/dL 9, 10.
eGFR of 39 mL/min/1.73m² confirms moderate kidney dysfunction, specifically CKD stage 3, as defined by the National Kidney Foundation 10, 11.

The American Heart Association defines chronic kidney disease as reduced excretory function with eGFR <60 mL/min/1.73m², which is associated with increased risk of cardiovascular disease, with approximately 16% higher cardiovascular mortality compared to those with normal kidney function 9, 11.
CKD stage 3 is associated with increased risk of cardiovascular disease, with a higher cardiovascular mortality rate compared to those with normal kidney function, as reported by the European Society of Cardiology 9, 10.

Diabetes mellitus is a potential cause of kidney dysfunction, as stated by the American Diabetes Association, and can lead to diabetic nephropathy 12.
Hypertension is a potential cause of kidney dysfunction, as stated by the American Heart Association, and can lead to hypertensive nephrosclerosis 9.
Multiple myeloma is a potential cause of kidney dysfunction, as stated by the National Comprehensive Cancer Network, and can lead to cast nephropathy or light chain deposition 7, 13, 14.

The American Diabetes Association recommends confirming persistence of abnormal values with repeat testing in 1-3 months to establish chronicity, and evaluating for albuminuria/proteinuria with spot urine albumin-to-creatinine ratio or 24-hour urine protein 12, 11.
The National Comprehensive Cancer Network recommends screening for potential causes, including complete urinalysis with microscopic examination, serum and urine protein electrophoresis, fasting glucose and HbA1c, complete blood count, and renal ultrasound 7, 15.

The American Diabetes Association recommends avoiding nephrotoxic medications, particularly NSAIDs, and maintaining adequate hydration to prevent further kidney function deterioration 12, 14.
The National Comprehensive Cancer Network recommends monitoring for medication dosing adjustments based on reduced kidney function, and considering nephrology referral, especially if rapid progression, significant proteinuria, or unclear etiology 15, 16.

The European Society of Cardiology warns against failing to consider non-renal causes of elevated BUN, such as high protein diet, gastrointestinal bleeding, or catabolic states 8.
The American Heart Association advises against assuming acute kidney injury when values may represent chronic disease, and neglecting to assess for medication effects, including supplements that may affect creatinine levels 9.